Neuralink has not yet begun human trials. In December 2022, Elon Musk said that he expected the company to start human trials in six months, but there has been no update since then. In March 2023, the FDA rejected Neuralink's application for a breakthrough device designation, which would have sped up the approval process. It is unclear when or if Neuralink will be able to begin human trials.

Neuralink has not yet begun human trials. In December 2022, Elon Musk said that he expected the company to start human trials in six months, but there has been no update since then. In March 2023, the FDA rejected Neuralink's application for a breakthrough device designation, which would have sped up the approval process. It is unclear when or if Neuralink will be able to begin human trials.

Here is a timeline of Neuralink's progress towards human trials:

• 2016: Neuralink is founded by Elon Musk, Max Hodak, and others.
• 2017: Neuralink announces its first product, a brain implant that can record and stimulate brain activity.
• 2018: Neuralink implants its first brain implant in a monkey.
• 2020: Neuralink implants its brain implant in a second monkey.
• 2021: Neuralink says it is on track to begin human trials in 2022.
• 2022: Elon Musk says he expects Neuralink to begin human trials in six months.
• 2023: The FDA rejects Neuralink's application for a breakthrough device designation.

It is important to note that Neuralink is still in the early stages of development, and there is no guarantee that its technology will be safe or effective in humans. The company has not yet published any peer-reviewed studies on its technology, and it is unclear how well it will work in people with neurological disorders.

Despite the risks, Neuralink's technology has the potential to revolutionize the way we treat neurological disorders. If successful, Neuralink could help people with conditions like paralysis, epilepsy, and Alzheimer's disease regain their mobility and cognitive function.